Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells

Breast Cancer Research and Treatment

Volumn 110, Issue 1, 2008, Pages 111-125

  Zheng, Ze Yi ^a,b,c   Zheng, Si Min ^a   Bay, Boon Huat ^b   Aw, Swee Eng ^c   Lin, Valerie C L ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Adenovirus mediated gene delivery; B upstream segment; Breast cancer; Estrogen receptor; Progesterone receptor

Indexed keywords

ADENOVIRUS VECTOR; ESTRADIOL; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B;

ADENOVIRUS; ARTICLE; BREAST CANCER; CELL DIFFERENTIATION; CELL GROWTH; CELL METABOLISM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMBRYO; ESTROGEN RESPONSIVE ELEMENT; HORMONE INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; AMINO ACID MOTIFS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GENE THERAPY; HUMANS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RESPONSE ELEMENTS;

EID: 44849128534     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9711-8     Document Type: Article

References (45)

1. Curtis Hewitt S, Couse JF, Korach KS (2000) Estrogen receptor transcription and transactivation: estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action. Breast Cancer Res 2:345-352
2. Conneely OM, Kettelberger DM, Tsai MJ, Schrader WT, O'Malley BW (1989) The chicken progesterone receptor A and B isoforms are products of an alternate translation initiation event. J Biol Chem 264:14062-14064
3. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P (1990) Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. Embo J 9:1603-1614
4. Takimoto GS, Tung L, Abdel-Hafiz H, Abel MG, Sartorius CA, Richer JK, Jacobsen BM, Bain DL, Horwitz KB (2003) Functional properties of the N-terminal region of progesterone receptors and their mechanistic relationship to structure. J Steroid Biochem Mol Biol 85:209-219
5. Shyamala G, Yang X, Silberstein G, Barcellos-Hoff MH, Dale E (1998) Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc Natl Acad Sci USA 95:696-701
6. Shyamala G, Louie SG, Camarillo IG, Talamantes F (1999) The progesterone receptor and its isoforms in mammary development. Mol Genet Metab 68:182-190
7. Clarke R, Liu MC, Bouker KB, Gu Z, Lee RY, Zhu Y, Skaar TC, Gomez B, O'Brien K, Wang Y et al (2003) Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 22:7316-7339
8. Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354:270-282
9. Skildum A, Faivre E, Lange CA (2005) Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Mol Endocrinol 19:327-339
10. Kalkhoven E, Kwakkenbos-Isbrucker L, de Laat SW, van der Saag PT, van der Burg B (1994) Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor. Mol Cell Endocrinol 102:45-52
11. Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange CA, Horwitz KB (1997) Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol 11:1593-1607
12. Alkhalaf M, El-Mowafy A, Karam S (2002) Growth inhibition of MCF-7 human breast cancer cells by progesterone is associated with cell differentiation and phosphorylation of Akt protein. Eur J Cancer Prev 11:481-488
13. Lin VC, Ng EH, Aw SE, Tan MG, Chan VS, Ho GH (1999) Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA. Clin Cancer Res 5:395-403
14. Lin VC, Eng AS, Hen NE, Ng EH, Chowdhury SH (2001) Effect of progesterone on the invasive properties and tumor growth of progesterone receptor-transfected breast cancer cells MDA-MB-231. Clin Cancer Res 7:2880-2886
15. Sedlacek SM (1988) An overview of megestrol acetate for the treatment of advanced breast cancer. Semin Oncol 15:3-13
16. Bezwoda WR, Gudgeon A, Falkson G, Jordaan JP, Goedhals L (1998) Fadrozole versus megestrol acetate: a double-blind randomised trial in advanced breast cancer. Oncology 55:416-420
17. Giangrande PH, Kimbrel EA, Edwards DP, McDonnell DP (2000) The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol 20:3102-3115
18. Katzenellenbogen BS (2000) Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways. J Soc Gynecol Investig 7:S33-S37
19. Chalbos D, Galtier F (1994) Differential effect of forms A and B of human progesterone receptor on estradiol-dependent transcription. J Biol Chem 269:23007-23012
20. Zheng ZY, Bay BH, Aw SE, Lin VC (2005) A novel antiestrogenic mechanism in progesterone receptor-transfected breast cancer cells. J Biol Chem 280:17480-17487
21. Mittereder N, March KL, Trapnell BC (1996) Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 70:7498-7509
22. Dai D, Kumar NS, Wolf DM, Leslie KK (2001) Molecular tools to reestablish progestin control of endometrial cancer cell proliferation. Am J Obstet Gynecol 184:790-797
23. Cao S, Iyer JK, Lin V (2006) Identification of tetratricopeptide repeat domain 9, a hormonally regulated protein. Biochem Biophys Res Commun 345:310-317
24. Leo JC, Wang SM, Guo CH, Aw SE, Zhao Y, Li JM, Hui KM, Lin VC (2005) Gene regulation profile reveals consistent anticancer properties of progesterone in hormone-independent breast cancer cells transfected with progesterone receptor. Int J Cancer 117:561-568
25. Sheridan PL, Francis MD, Horwitz KB (1989) Synthesis of human progesterone receptors in T47D cells. Nascent A- and B-receptors are active without a phosphorylation-dependent post-translational maturation step. J Biol Chem 264:7054-7058
26. Sartorius CA, Melville MY, Hovland AR, Tung L, Takimoto GS, Horwitz KB (1994) A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol 8:1347-1360
27. Tung L, Mohamed MK, Hoeffler JP, Takimoto GS, Horwitz KB (1993) Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol Endocrinol 7:1256-1265
28. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP (1993) Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 7:1244-1255
29. Pratt WB, Galigniana MD, Morishima Y, Murphy PJ (2004) Role of molecular chaperones in steroid receptor action. Essays Biochem 40:41-58
30. DeFranco DB, Csermely P (2000) Steroid receptor and molecular chaperone encounters in the nucleus. Sci STKE 2000:PE1
31. Tetel MJ, Giangrande PH, Leonhardt SA, McDonnell DP, Edwards DP (1999) Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol Endocrinol 13:910-924
32. Tung L, Shen T, Abel MG, Powell RL, Takimoto GS, Sartorius CA, Horwitz KB (2001) Mapping the unique activation function 3 in the progesterone B-receptor upstream segment. Two LXXLL motifs and a tryptophan residue are required for activity. J Biol Chem 276:39843-39851
33. Robyr D, Wolffe AP, Wahli W (2000) Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol Endocrinol 14:329-347
34. Ballare C, Uhrig M, Bechtold T, Sancho E, Di Domenico M, Migliaccio A, Auricchio F, Beato M (2003) Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells. Mol Cell Biol 23:1994-2008
35. Dong X, Challis JR, Lye SJ (2004) Intramolecular interactions between the AF3 domain and the C-terminus of the human progesterone receptor are mediated through two LXXLL motifs. J Mol Endocrinol 32:843-857
36. Tung L, Abdel-Hafiz H, Shen T, Harvell DM, Nitao LK, Richer JK, Sartorius CA, Takimoto GS, Horwitz KB (2006) Progesterone Receptors (PR)-B and PR-A Regulate Transcription by Different Mechanisms: Af-3 Exerts Regulatory Control over Coactivator Binding to PR-B. Mol Endocrinol 20:2656-2670
37. Onate SA, Boonyaratanakornkit V, Spencer TE, Tsai SY, Tsai MJ, Edwards DP, O'Malley BW (1998) The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J Biol Chem 273:12101-12108
38. Graham JD, Yager ML, Hill HD, Byth K, O'Neill GM, Clarke CL (2005) Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells. Mol Endocrinol 19:2713-2735
39. Sartorius CA, Shen T, Horwitz KB (2003) Progesterone receptors A and B differentially affect the growth of estrogen-dependent human breast tumor xenografts. Breast Cancer Res Treat 79:287-299
40. Weigel NL, Zhang Y (1998) Ligand-independent activation of steroid hormone receptors. J Mol Med 76:469-479
41. Jacobsen BM, Schittone SA, Richer JK, Horwitz KB (2005) Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology. Mol Endocrinol 19:574-587
42. Thornton JW (2001) Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proc Natl Acad Sci USA 98:5671-5676
43. Thornton JW, Need E, Crews D (2003) Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling. Science 301:1714-1717
44. Hopp TA, Weiss HL, Hilsenbeck SG, Cui Y, Allred DC, Horwitz KB, Fuqua SA (2004) Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates. Clin Cancer Res 10:2751-2760
45. Sakaguchi H, Fujimoto J, Hong BL, Nakagawa Y, Tamaya T (2004) Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers. Gynecol Oncol 93:394-399